Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
Kimberly-Clark (KMB) Posts +17.2% EPS Growth in Q3 2026

Kimberly-Clark (KMB) Posts +17.2% EPS Growth in Q3 2026

Key Takeaways

  • Net sales came in at $4.1 billion, down 0.4% from a year ago, while organic sales declined 1.3%.
  • Adjusted earnings per share (EPS) from continuing operations reached $1.70, beating the consensus estimate of $1.61 by $0.09 and rising 17.2% year over year.
  • North America delivered 2.0% volume-led growth, but International Personal Care (IPC) operating profit fell 32.7% amid a China social media disruption.
  • Adjusted gross margin slipped 130 basis points to 35.5% on unfavorable pricing net of cost inflation and supply chain investments.
  • Kimberly-Clark reaffirmed its full-year 2026 outlook and completed its acquisition of Kenvue on November 2, 2026.
  • The company returned roughly $1.3 billion to shareholders through dividends in the first nine months and declared a $1.28-per-share quarterly dividend.

Why These Results Matter at This Stage

Kimberly-Clark’s third-quarter 2026 numbers arrive at an important inflection point for the consumer staples company. This marks the first update after the close of its major KMB acquisition of Kenvue, which wrapped up on November 2, 2026. The focus now shifts to whether strong volume trends in North America can counterbalance the disruption in International Personal Care stemming from events in China. With pricing pressure evident in several areas and costs still elevated, the quarter provides a useful check on margin durability and the company’s ability to extend its long dividend-growth record.

What the Quarter Actually Delivered

KMB posted net sales of $4.1 billion for the quarter, a 0.4% decline from the prior year. Organic sales fell 1.3%, including roughly a 270-basis-point impact from the China social media issue and North American inventory shifts. Gross margin stood at 34.9%, while the adjusted figure came in at 35.5%, down 130 basis points year over year.

Adjusted EPS from continuing operations climbed 17.2% to $1.70, clearing the $1.61 consensus. Revenue of $4.13 billion also exceeded the $4.11 billion analyst target. Diluted EPS attributable to KMB reached $5.37, aided by a roughly $1.4 billion gain tied to the International Family Care and Professional transaction; stripping that out left adjusted EPS at $1.70, down 6.6%.

North America net sales rose 0.9% to $2.7 billion, supported by 2.0% volume growth in Family Care and Professional, with segment operating profit advancing 2.7% to $657 million. International Personal Care net sales declined 2.8% to $1.4 billion, and operating profit dropped 32.7% to $144 million. Management kept its 2026 standalone guidance intact. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction and Current Sentiment

Shares of KMB eased modestly after the release even though both revenue and EPS topped expectations. Investors appeared to focus on the China-related pressure and the added complexity of integrating Kenvue. The measured response highlights how those headwinds are currently overshadowing the solid North American volume performance. Sentiment stays cautiously constructive, with management noting that the core business remains healthy and that the China matter originated from false information the company plans to address over time.

Outlook and Items Worth Tracking

KMB reaffirmed its 2026 targets, projecting organic sales growth roughly 100 basis points below its weighted average category growth of about 1.7%. Adjusted operating profit is expected to increase in the mid-single digits on a constant-currency basis, while adjusted EPS from continuing operations should rise in the high single digits.

Key areas to follow include the recovery pace in China, which could swing results for the International Personal Care segment. The company has indicated it will continue investing to regain market position, which may keep near-term margins under some pressure. The Kenvue integration now takes center stage, with a three-phase “ready, set, grow” approach and a goal of returning to approximately two times leverage by the end of the second year post-deal. Synergy realization, brand turnarounds, and SKU rationalization will be important to watch. Cost trends also merit attention given ongoing pressures despite lower oil prices. Productivity gains and an easier North American comparison in the fourth quarter could offer support, though promotional activity and retailer inventory moves remain variables.

Adding Tickeron’s AI Tools to My Routine

From what I see, Tickeron’s AI tools have become a regular part of how I cross-check earnings trends and peer comparisons. The AI Screener helps surface relevant patterns quickly, while the AI Trend Prediction Engine offers an additional lens on momentum. These resources let me validate ideas without replacing my own analysis, and I find the combination keeps my process more efficient when reviewing names like KMB.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: KMB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


KMB's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for KMB moved out of overbought territory on October 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 instances where the indicator moved out of the overbought zone. In 21 of the 35 cases the stock moved lower in the days that followed. This puts the odds of a move down at 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for KMB turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 23 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

KMB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on KMB as a result. In 38 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 42%.

KMB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KMB crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +6.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMB advanced for three days, in 128 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.

The Aroon Indicator entered an Uptrend today. In 81 of 192 cases where KMB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 42%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. KMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.675) is normal, around the industry mean (21.072). P/E Ratio (18.470) is within average values for comparable stocks, (16.552). Projected Growth (PEG Ratio) (2.018) is also within normal values, averaging (1.518). Dividend Yield (0.047) settles around the average of (0.033) among similar stocks. P/S Ratio (1.971) is also within normal values, averaging (1.902).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 24.68B. The market cap for tickers in the group ranges from 60.48K to 388.63B. PG holds the highest valuation in this group at 388.63B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 12%. HELE experienced the highest price growth at 26%, while YSG experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 155%. For the same stocks of the Industry, the average monthly volume growth was 146% and the average quarterly volume growth was 84%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the manufacturing of paper based products and providing cleaning solutions

Industry HouseholdPersonalCare

Industry
Household Or Personal Care
Address
P.O. Box 619100
Phone
+1 972 281-1200
Employees
36000
Web
https://www.kimberly-clark.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
ExxonMobil reported GAAP net earnings of $4.2 billion, or $1.00 per diluted share (EPS), down from $7.7 billion, or $1.76 per share, in Q1 2025. Adjusted earnings excluding identified items reached $4.9 billion, or $1.16 per share, surpassing consensus estimates around $1.00 to $1.07.